Advanced Accelerator Application SA (ADR) (NASDAQ:AAAP) has announced the expansion of its theranostic pipeline with the addition of NeoBOMB1, which it describes as a novel GRPR antagonist. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback